Results 251 to 260 of about 127,911,481 (277)
Some of the next articles are maybe not open access.
Lab on a Chip, 2022
3D tumor models are emerging as valuable tools for drug screening and nanoparticle based personalized cancer treatments. The main challenges in building microfluidic chip-based 3D tumor models currently include the development of bioinks with high ...
You Chen +7 more
semanticscholar +1 more source
3D tumor models are emerging as valuable tools for drug screening and nanoparticle based personalized cancer treatments. The main challenges in building microfluidic chip-based 3D tumor models currently include the development of bioinks with high ...
You Chen +7 more
semanticscholar +1 more source
Tumor-on-a-chip devices for cancer immunotherapy
Engineering Technologies and Clinical Translation, 2022This chapter introduces a range of microfluidics-based approaches to the manipulation of immune cells and the recapitulation of the tumor microenvironment, i.e., Tumor-on-a-Chip, for elucidating the mechanism of immune surveillance and for advancing ...
X. Mu, Y. S. Zhang
semanticscholar +1 more source
Vascularized tumor-on-a-chip to investigate immunosuppression of CAR-T cells.
Lab on a ChipChimeric antigen receptor (CAR)-T cell immunotherapy, effective in blood cancers, shows limited success in solid tumors, such as prostate, pancreatic, and brain cancers due, in part, to an immunosuppressive tumor microenvironment (TME). Immunosuppression
Rajul S Bains +7 more
semanticscholar +1 more source
ACS Biomaterials Science & Engineering, 2022
Prolyl hydroxylases (PHD) inhibitors have been observed to improve drug distribution in mice tumors via blood vessel normalization, increasing the effectiveness of chemotherapy. These effects are yet to be demonstrated in human cell models.
Zhiwei Hu +9 more
semanticscholar +1 more source
Prolyl hydroxylases (PHD) inhibitors have been observed to improve drug distribution in mice tumors via blood vessel normalization, increasing the effectiveness of chemotherapy. These effects are yet to be demonstrated in human cell models.
Zhiwei Hu +9 more
semanticscholar +1 more source
DLM-GelMA/tumor slice sandwich structured tumor on a chip for drug efficacy testing.
Lab on a ChipThe in vitro recapitulation of tumor microenvironment is of great interest to preclinical screening of drugs. Compared with culture of cell lines, tumor organ slices can better preserve the complex tumor architecture and phenotypic activity of native ...
Wenqi Hu +13 more
semanticscholar +1 more source
Cancer Chemistry, 2019
Biomimetic tissue engineered microfluidic cancer models offer a higher degree of spatial, temporal and structural precision in controlling the physical parameters and component characteristics of the native tumor microenvironment (TME).
Benjamin Anbiah +7 more
semanticscholar +1 more source
Biomimetic tissue engineered microfluidic cancer models offer a higher degree of spatial, temporal and structural precision in controlling the physical parameters and component characteristics of the native tumor microenvironment (TME).
Benjamin Anbiah +7 more
semanticscholar +1 more source
Lab on a Chip, 2019
The field of microfluidics-based three-dimensional (3D) cell culture system is rapidly progressing from academic proof-of-concept studies to valid solutions to real-world problems.
Jihoon Ko +6 more
semanticscholar +1 more source
The field of microfluidics-based three-dimensional (3D) cell culture system is rapidly progressing from academic proof-of-concept studies to valid solutions to real-world problems.
Jihoon Ko +6 more
semanticscholar +1 more source
Trends in Biotechnology
Radiation therapy precisely targets tumors with ionizing radiation, aiming to achieve local control while minimizing collateral damage to surrounding healthy tissues. Radiation research is often carried out in animal models, but these suffer from ethical
R. Nasiri, A. Sankaranthi, G. Pratx
semanticscholar +1 more source
Radiation therapy precisely targets tumors with ionizing radiation, aiming to achieve local control while minimizing collateral damage to surrounding healthy tissues. Radiation research is often carried out in animal models, but these suffer from ethical
R. Nasiri, A. Sankaranthi, G. Pratx
semanticscholar +1 more source
Advanced Healthcare Materials
Evolving knowledge about the tumor–immune microenvironment (TIME) is driving innovation in designing novel therapies against hard‐to‐treat breast cancer.
Twinkle Jina Minette Manoharan +4 more
semanticscholar +1 more source
Evolving knowledge about the tumor–immune microenvironment (TIME) is driving innovation in designing novel therapies against hard‐to‐treat breast cancer.
Twinkle Jina Minette Manoharan +4 more
semanticscholar +1 more source
Electro Kinetic and Flow Analysis in Microfluidic Lab on a Chip for Brain Tumor Biomarkers
International Conference on Communication and Electronics SystemsModern labs on a chip microfluidics system are highly suited to patient diagnostics at the precise point when they are inventive and accurate enough to assess medications for early identification.
P. Balaji +5 more
semanticscholar +1 more source

